![Loading Events](https://espanol.natividad.com/wp-content/plugins/the-events-calendar/src/resources/images/tribe-loading.gif)
- This event has passed.
How Far Have We Come? Emerging Therapies for Fibromyalgia and Chronic Fatigue Syndrome.
November 14, 2017 @ 12:00 pm - 1:00 pm
Free![]( https://espanol.natividad.com/wp-content/uploads/2018/04/171114-Pritzlaff-300x300.png)
Department of Anesthesiology, Perioperative and Pain Medicine
Interventional Pain Specialist
Stanford University School of Medicine
Speaker for this CME Activity: Scott G. Pritzlaff, MD
Location: S.E.A. Conference Room
Fibromyalgia and chronic fatigue syndrome are often misunderstood conditions responsible for significant disability. It is critical for primary care and pain providers to have a sound understanding of the diagnostic criteria and treatment options for these patients.
Desired Outcomes:
- Review the epidemiology of fibromyalgia and other syndromes that may overlap.
- Explain the American College of Rheumatology (ACR) diagnostic criteria for fibromyalgia.
- Discuss the etiology of chronic fatigue syndrome such as infection, immune dysfunction, endocrine-metabolic dysfunction, depression.
- Select appropriate pharmacologic and non-pharmacologic treatments for fibromyalgia pain management and chronic fatigue syndrome.